UBE2Q2: Ubiquitin Conjugating Enzyme E2 Q2

A ubiquitin-conjugating enzyme involved in protein degradation and cellular signaling

Gene Information Card

Symbol UBE2Q2
Full Name Ubiquitin Conjugating Enzyme E2 Q2
Gene Type Protein coding
Chromosomal Location 15q24.2
NCBI Gene ID 92912 ncbi.nlm.nih.gov/gene/92912
Ensembl ID ENSG00000140319
UniProt ID Q8WVN6
OMIM ID 617591
HGNC ID 20087
Aliases UBE2Q, UBCQ2, UBE2Q2P1

Description

UBE2Q2 encodes a member of the ubiquitin-conjugating enzyme (E2) family. This enzyme catalyzes the second step in ubiquitin conjugation, transferring ubiquitin from the E1 complex to a specific E3 ligase, thereby targeting proteins for proteasomal degradation or modifying their function. UBE2Q2 is involved in cell cycle regulation, apoptosis, and response to cellular stress. Dysregulation has been implicated in several cancers and neurodegenerative disorders.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Breast cancer Overexpression of UBE2Q2 promotes proliferation and inhibits apoptosis via ubiquitination of p53 and other tumor suppressors. PMID: 25605274
Colorectal cancer UBE2Q2 upregulation correlates with poor prognosis and enhanced Wnt/β-catenin signaling. PMID: 29367642
Hepatocellular carcinoma UBE2Q2 overexpression enhances cell migration and invasion through EMT induction. PMID: 31034567
Parkinson's disease UBE2Q2 interacts with parkin and may influence ubiquitination of α-synuclein. PMID: 21752920

Expression Profile

Tissue Expression
Tissue nTPM level
Testis 12.5 Medium
Brain 8.3 Medium
Liver 6.1 Low
Kidney 5.4 Low
Heart 4.2 Low
Cell Line Expression
Cell Line nTPM Notes
HEK293 15.2 High expression
HeLa 10.8 Medium expression
MCF7 9.5 Medium expression
HepG2 7.3 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.511C>T (p.Arg171Trp) Missense <0.01% Unknown functional effect
c.724G>A (p.Glu242Lys) Missense <0.01% Unknown functional effect
c.1003_1004insA Frameshift <0.01% Predicted loss of function
Mutation functional classification

Loss of Function (LOF)

Frameshift mutations (e.g., c.1003_1004insA) are predicted to cause premature truncation and loss of enzymatic activity.

Gain of Function (GOF)

No confirmed gain-of-function mutations reported.

Dominant Negative (DN)

Not established for UBE2Q2.

Pathways

• Ubiquitin mediated proteolysis (KEGG: hsa04120)
• Protein processing in endoplasmic reticulum (KEGG: hsa04141)
• p53 signaling pathway (KEGG: hsa04115)

Protein Summary

UBE2Q2 is a 421-amino acid ubiquitin-conjugating enzyme (E2) with a conserved UBC domain. It accepts ubiquitin from the E1 activating enzyme and transfers it to E3 ligases, which then attach ubiquitin to target proteins. UBE2Q2 is widely expressed, with highest levels in testis and brain. It plays roles in cell cycle control, apoptosis, and stress responses. Altered expression is linked to cancer progression and neurodegeneration.

Related Products

Product name Cat.No. Species Gene ID
UBE2Q2 Knockout HeLa Cell Line EDJ-KQ39080 Human 92912 Details Get a Quote
UBE2Q2 Knockout HCT 116 Cell Line EDJ-KQ39079 Human 92912 Details Get a Quote
UBE2Q2 Knockout A-549 Cell Line EDJ-KQ39077 Human 92912 Details Get a Quote
UBE2Q2 Knockout HEK293 Cell Line EDJ-KQ10411 Human 92912 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: